FR1898M - Nouvelle substance utilisable en thérapeutique. - Google Patents

Nouvelle substance utilisable en thérapeutique.

Info

Publication number
FR1898M
FR1898M FR893721A FR893721A FR1898M FR 1898 M FR1898 M FR 1898M FR 893721 A FR893721 A FR 893721A FR 893721 A FR893721 A FR 893721A FR 1898 M FR1898 M FR 1898M
Authority
FR
France
Prior art keywords
therapy
new substance
substance usable
usable
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR893721A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH407561A external-priority patent/CH415684A/de
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR1898M publication Critical patent/FR1898M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR893721A 1961-04-07 1962-04-07 Nouvelle substance utilisable en thérapeutique. Expired FR1898M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH407561A CH415684A (de) 1961-04-07 1961-04-07 Verfahren zur Herstellung neuer Hydroxylaminverbindungen
CH488561 1961-04-26

Publications (1)

Publication Number Publication Date
FR1898M true FR1898M (fr) 1963-07-08

Family

ID=32327272

Family Applications (1)

Application Number Title Priority Date Filing Date
FR893721A Expired FR1898M (fr) 1961-04-07 1962-04-07 Nouvelle substance utilisable en thérapeutique.

Country Status (1)

Country Link
FR (1) FR1898M (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024451A1 (fr) * 1992-06-03 1993-12-09 Ciba-Geigy Ag Sels de desferrioxamine-b et leur utilisation comme chelateurs de fer a efficacite orale
WO1998025887A3 (fr) * 1996-12-10 1998-08-13 Novartis Ag Formulations et formes polymorphes de desferrioxamine et rpeparation de ces dernieres
EP1235791A4 (fr) * 1999-12-01 2006-03-08 Teva Gyogyszergyar Reszvenytar Procede a etapes multiples pour la preparation de sel de deferoxamine sous forme de methanesulfonate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024451A1 (fr) * 1992-06-03 1993-12-09 Ciba-Geigy Ag Sels de desferrioxamine-b et leur utilisation comme chelateurs de fer a efficacite orale
WO1998025887A3 (fr) * 1996-12-10 1998-08-13 Novartis Ag Formulations et formes polymorphes de desferrioxamine et rpeparation de ces dernieres
EP1235791A4 (fr) * 1999-12-01 2006-03-08 Teva Gyogyszergyar Reszvenytar Procede a etapes multiples pour la preparation de sel de deferoxamine sous forme de methanesulfonate

Similar Documents

Publication Publication Date Title
CH424813A (de) Walze
FR1724M (fr) Halogénoaralkyl-biguanides.
DK105682C (da) Posebundt.
FR2770M (fr) Nouvelles dihalogéno-amino-benzylamines.
DK103819C (da) Lidsespiraltov.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR3377M (fr) Pommade utilisable en ophtalmologie.
FR1787M (fr) 3-phénoxy-propylguanidine.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR1736M (fr) Agent opacifiant utilisable en radiologie.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR164M (fr) Nouvelle hydrazine utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
FR349M (fr) Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.
FR221M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR1269M (fr) Dihydrostreptomycine suractivée.
FR1899M (fr) Nouvelle substance thérapeutiquement utilisable.
FR1503M (fr) Anisoxy-éthylamines.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
FR1494M (fr) Nouvelle création en thérapeutique.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.